Skip to content

Clinical trials

Completed Phase 1 Retinal Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Phase: Phase 1 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20103
20141
20151
20181
20191
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Adverum Biotechnologies, Inc.1
Gemini Therapeutics, Inc.1
Genzyme, a Sanofi Company1
Opthea Limited1
PYC Therapeutics1
Quark Pharmaceuticals1
University of California, Davis1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration10
Eye Diseases6
Macular Degeneration6
Retinal Diseases4
Blindness1
Geographic Atrophy1
Glaucoma, Open-Angle1
Neovascularization, Pathologic1
Optic Atrophy1
Optic Atrophy, Hereditary, Leber1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.